Allred Capital Management, LLC Biomarin Pharmaceutical Inc Transaction History

Allred Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$75.51 - $84.79 $14,120 - $15,855	-187 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$74.73 - $90.69 $32,507 - $39,450	-435 Reduced 69.94%	187 $14,000
Q1 2020 Apr 17, 2020	BUY	$71.37 - $96.85 $1,570 - $2,130	22 Added 3.67%	622 $52.6 Million
Q4 2019 Jan 13, 2020	BUY	$64.27 - $86.37 $38,562 - $51,822	600 New	600 $50,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.